Get the app!
Back to Trades

Shah Gaurav

CEOCIK 0001725922

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
9
Buy transactions
0
Sell transactions
8
Companies
1
Active
2025–2026

Across 9 filings between 2025–2026, Shah Gaurav, CEO, has disclosed $545.7K in transactions — all concentrated in ROCKET PHARMACEUTICALS, INC. (RCKT). Their disclosed trades are heavily weighted toward selling — $0 in buys and $280.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

9 loaded
Nov 20RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravCEOSell$4.8K
Nov 17RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$6.8K
Aug 20RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$7.8K
Aug 17RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$9.6K
May 26RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$171.8K
Feb 20RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$20.0K
Feb 18RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$40.7K
Nov 20RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderSell$18.7K
Aug 20RCKT
ROCKET PHARMACEUTICALS, INC.
Shah GauravInsiderTax withheld$6.8K

9 filings